{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:29:57Z","timestamp":1764700197424},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T00:00:00Z","timestamp":1182902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1038\/sj.ejhg.5201884","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T05:23:57Z","timestamp":1182921837000},"page":"1049-1053","source":"Crossref","is-referenced-by-count":41,"title":["Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population"],"prefix":"10.1038","volume":"15","author":[{"given":"Baorui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jifeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,27]]},"reference":[{"key":"BF5201884_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P : Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"BF5201884_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/1471-2407-6-274","volume":"6","author":"S Sadighi","year":"2006","unstructured":"Sadighi S, Mohagheghi MA, Montazeri A, Sadighi Z : Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF). BMC Cancer 2006; 6: 274.","journal-title":"BMC Cancer"},{"key":"BF5201884_CR3","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1038\/sj.bjc.6602572","volume":"92","author":"K Sumpter","year":"2005","unstructured":"Sumpter K, Harper-Wynne C, Cunningham D et al: Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF. Br J Cancer 2005; 92: 1976\u20131983.","journal-title":"Br J Cancer"},{"key":"BF5201884_CR4","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","volume":"24","author":"E Van Cutsem","year":"2006","unstructured":"Van Cutsem E, Moiseyenko VM, Tjulandin S et al: Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006; 24: 4991\u20134997.","journal-title":"J Clin Oncol"},{"key":"BF5201884_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.coph.2006.01.011","volume":"6","author":"R Rosell","year":"2006","unstructured":"Rosell R, Cecere F, Santarpia M, Reguart N, Taron M : Predicting the outcome of chemotherapy for lung cancer. Curr Opin Pharmacol 2006; 6: 323\u2013331.","journal-title":"Curr Opin Pharmacol"},{"key":"BF5201884_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1056\/NEJMoa060570","volume":"355","author":"KA Olaussen","year":"2006","unstructured":"Olaussen KA, Dunant A, Fouret P et al: DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006; 355: 983\u2013991.","journal-title":"N Engl J Med"},{"key":"BF5201884_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.bjc.6601487","volume":"90","author":"S Marsh","year":"2004","unstructured":"Marsh S, McLeod HL : Cancer pharmacogenetics. Br J Cancer 2004; 90: 8\u201311.","journal-title":"Br J Cancer"},{"key":"BF5201884_CR8","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","volume":"22","author":"S Gurubhagavatula","year":"2004","unstructured":"Gurubhagavatula S, Liu G, Park S et al: XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 2004; 22: 2594\u20132601.","journal-title":"J Clin Oncol"},{"key":"BF5201884_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-4598-4-18","volume":"4","author":"DA Weaver","year":"2005","unstructured":"Weaver DA, Crawford EL, Warner KA, Elkhairi F, Khuder SA, Willey JC : ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. Mol Cancer 2005; 4: 18.","journal-title":"Mol Cancer"},{"key":"BF5201884_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/10409239509083491","volume":"30","author":"JD Hayes","year":"1995","unstructured":"Hayes JD, Pulford DJ : The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30: 445\u2013600.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"BF5201884_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/carcin\/19.2.275","volume":"19","author":"MA Watson","year":"1998","unstructured":"Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA : Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19: 275\u2013280.","journal-title":"Carcinogenesis"},{"key":"BF5201884_CR12","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1093\/nar\/gki543","volume":"33","author":"R Brem","year":"2005","unstructured":"Brem R, Hall J : XRCC1 is required for DNA single-strand break repair in human cells. Nucleic Acids Res 2005; 33: 2512\u20132520.","journal-title":"Nucleic Acids Res"},{"key":"BF5201884_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.dnarep.2006.10.002","volume":"6","author":"ZK Nazarkina","year":"2007","unstructured":"Nazarkina ZK, Khodyreva SN, Marsin S, Lavrik OI, Radicella JP : XRCC1 interactions with base excision repair DNA intermediates. DNA Repair (Amst) 2007; 6: 254\u2013264.","journal-title":"DNA Repair (Amst)"},{"key":"BF5201884_CR14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1158\/1055-9965.801.13.5","volume":"13","author":"S Savas","year":"2004","unstructured":"Savas S, Kim DY, Ahmad MF, Shariff M, Ozcelik H : Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol Biomarkers Prev 2004; 13: 801\u2013807.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF5201884_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.lungcan.2006.08.009","volume":"54","author":"C Kiyohara","year":"2006","unstructured":"Kiyohara C, Takayama K, Nakanishi Y : Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006; 54: 267\u2013283.","journal-title":"Lung Cancer"},{"key":"BF5201884_CR16","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1158\/1055-9965.EPI-06-0381","volume":"15","author":"MC Stern","year":"2006","unstructured":"Stern MC, Siegmund KD, Conti DV, Corral R, Haile RW : XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 2384\u20132390.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF5201884_CR17","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/carcin\/bgi084","volume":"26","author":"WY Huang","year":"2005","unstructured":"Huang WY, Chow WH, Rothman N et al: Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis 2005; 26: 1354\u20131359.","journal-title":"Carcinogenesis"},{"key":"BF5201884_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejca.2006.11.005","volume":"43","author":"H Hirata","year":"2007","unstructured":"Hirata H, Hinoda Y, Tanaka Y et al: Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer 2007; 43: 231\u2013237.","journal-title":"Eur J Cancer"},{"key":"BF5201884_CR19","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1245\/s10434-006-9112-y","volume":"13","author":"KW Suh","year":"2006","unstructured":"Suh KW, Kim JH, Kim do Y, Kim YB, Lee C, Choi S : Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene? Ann Surg Oncol 2006; 13: 1379\u20131385.","journal-title":"Ann Surg Oncol"},{"key":"BF5201884_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/annonc\/mdj135","volume":"17","author":"R de las Penas","year":"2006","unstructured":"de las Penas R, Sanchez-Ronco M, Alberola V et al: Spanish Lung Cancer Group. Polymorphisms in DNA repair genes modulate survival in cisplatin\/gemcitabine-treated non-small-cell lung cancer patients. Ann Oncol 2006; 17: 668\u2013675.","journal-title":"Ann Oncol"},{"key":"BF5201884_CR21","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1200\/JCO.2006.05.9923","volume":"24","author":"MA Bewick","year":"2006","unstructured":"Bewick MA, Conlon MS, Lafrenie RM : Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol 2006; 24: 5645\u20135651.","journal-title":"J Clin Oncol"},{"key":"BF5201884_CR22","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1200\/JCO.2005.03.6640","volume":"4","author":"X Wu","year":"2006","unstructured":"Wu X, Gu J, Wu TT et al: Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol 2006; 4: 3789\u20133798.","journal-title":"J Clin Oncol"},{"key":"BF5201884_CR23","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1200\/JCO.2005.04.8322","volume":"24","author":"A Ruzzo","year":"2006","unstructured":"Ruzzo A, Graziano F, Kawakami K et al: Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy. J Clin Oncol 2006; 24: 1883\u20131891.","journal-title":"J Clin Oncol"},{"key":"BF5201884_CR24","first-page":"8654","volume":"61","author":"DJ Park","year":"2001","unstructured":"Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ : A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 2001; 61: 8654\u20138658.","journal-title":"Cancer Res"},{"key":"BF5201884_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","volume":"44","author":"JS Ryu","year":"2004","unstructured":"Ryu JS, Hong YC, Han HS et al: Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Lung Cancer 2004; 44: 311\u2013316.","journal-title":"Lung Cancer"},{"key":"BF5201884_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdh319","volume":"15","author":"D Isla","year":"2004","unstructured":"Isla D, Sarries C, Rosell R et al: Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer. Ann Oncol 2004; 15: 1194\u20131203.","journal-title":"Ann Oncol"},{"key":"BF5201884_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","volume":"91","author":"J Stoehlmacher","year":"2004","unstructured":"Stoehlmacher J, Park DJ, Zhang W et al: A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 2004; 91: 344\u2013354.","journal-title":"Br J Cancer"},{"key":"BF5201884_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0169-5002(02)00184-8","volume":"38","author":"D Xing","year":"2002","unstructured":"Xing D, Tan W, Wei Q, Lin D : Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer 2002; 38: 123\u2013129.","journal-title":"Lung Cancer"},{"key":"BF5201884_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/cncr.20729","volume":"103","author":"G Yang","year":"2005","unstructured":"Yang G, Shu XO, Ruan ZX et al: Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma. Cancer 2005; 103: 52\u201358.","journal-title":"Cancer"},{"key":"BF5201884_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.bjc.6602891","volume":"94","author":"E Goekkurt","year":"2006","unstructured":"Goekkurt E, Hoehn S, Wolschke C et al: Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients. Br J Cancer 2006; 94: 281\u2013286.","journal-title":"Br J Cancer"},{"key":"BF5201884_CR31","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnci\/94.12.936","volume":"94","author":"J Stoehlmacher","year":"2002","unstructured":"Stoehlmacher J, Park DJ, Zhang W et al: Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst 2002; 94: 936\u2013942.","journal-title":"J Natl Cancer Inst"},{"key":"BF5201884_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd1691","volume":"4","author":"D Wang","year":"2005","unstructured":"Wang D, Lippard SJ : Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005; 4: 307\u2013320.","journal-title":"Nat Rev Drug Discov"},{"key":"BF5201884_CR33","first-page":"2620","volume":"5","author":"M Nishiyama","year":"1999","unstructured":"Nishiyama M, Yamamoto W, Park JS et al: Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves. Clin Cancer Res 1999; 5: 2620\u20132628.","journal-title":"Clin Cancer Res"},{"key":"BF5201884_CR34","first-page":"336","volume":"112","author":"M Zhan","year":"1999","unstructured":"Zhan M, Liu X : Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP. Chin Med J (Engl) 1999; 112: 336\u2013339.","journal-title":"Chin Med J (Engl)"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/5201884.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201884","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201884.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T13:50:20Z","timestamp":1708005020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/5201884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,27]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["BF5201884"],"URL":"https:\/\/doi.org\/10.1038\/sj.ejhg.5201884","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,27]]}}}